BRIDGE for Young-Onset Alzheimer’s Disease Act of 2025

Summary of HR 6799 (119th Congress) – BRIDGE for Young-Onset Alzheimer’s Disease Act of 2025

Purpose

HR 6799 seeks to modify Social Security provisions to remove waiting periods for disability insurance benefits and to eliminate the Medicare 24-month waiting period specifically for individuals diagnosed with young-onset Alzheimer's disease. The bill is titled the BRIDGE for Young-Onset Alzheimer’s Disease Act of 2025.

Key Provisions

• Elimination of waiting period for Disability Insurance Benefits (DIB):

  • Amends Section 223(a) of the Social Security Act to add young-onset Alzheimer's disease to the conditions that trigger eligibility for disability insurance benefits without the standard waiting period.
  • The change would apply to applications filed after a date 5 months prior to enactment.

• Waiver of 24-month Medicare waiting period:

  • Amends Section 226(h) of the Social Security Act to include young-onset Alzheimer's disease alongside ALS as conditions with no Medicare 24-month waiting period.
  • The changes apply to Medicare benefits for months beginning after enactment.

• Definition and scope:

  • The act defines “young-onset Alzheimer's” as determined by the Commissioner through the Program Operations Manual System (POMS) or a successor document. This mirrors existing definitions used for other conditions (e.g., ALS) within the act.

• Effective dates:

  • Disability benefits waiting-period waiver: applies to DIB applications filed after a date that is 5 months before the enactment date.
  • Medicare waiting-period waiver: applies to Medicare-covered benefits for months after enactment.

Affected Parties

• Individuals with young-onset Alzheimer’s disease: Primary beneficiaries who would no longer face the typical disability insurance waiting period and the Medicare 24-month waiting period.
• Social Security Administration (SSA): Agencies responsible for implementing and administering DIB and Medicare-related provisions would need to align with the new definitions and effective dates.
• Potential caregivers and families: May experience earlier access to benefits and associated Medicare coverage, affecting planning and care decisions.
• Current and prospective beneficiaries: The changes could alter qualification timing for benefits and coverage compared to current law.

Procedural and Timeline Considerations

• Enactment timing: Provisions become effective for benefits and applications in relation to enactment dates:
  • DIB: Applies to applications filed after a date that is 5 months before enactment.
  • Medicare: Applies to months beginning after enactment.
• Definition mechanics: The term “young-onset Alzheimer’s” is defined by SSA’s Commissioner via the Program Operations Manual System (or successor), indicating reliance on SSA guidelines to determine qualifying cases.

Additional Context

• The bill maintains the overall framework of the Social Security Act while expanding eligibility triggers to include young-onset Alzheimer's disease in the same manner as other conditions that currently qualify for expedited or waivered waiting periods.
• As introduced, HR 6799 has multiple co-sponsors, indicating bipartisan or cross-party support among several Representatives.

Conclusion

HR 6799 aims to reduce delay in benefits and coverage for individuals diagnosed with young-onset Alzheimer's disease by removing the standard waiting periods for both disability benefits and Medicare. If enacted, eligible applicants could receive earlier financial support and health coverage, with SSA referencing the definition of young-onset Alzheimer's through its official operation manuals.